Literature DB >> 28942366

Regulatory T Cells Mediate Local Immunosuppression in Lymphedema.

Gabriela D García Nores1, Catherine L Ly1, Ira L Savetsky1, Raghu P Kataru1, Swapna Ghanta1, Geoffrey E Hespe1, Stanley G Rockson2, Babak J Mehrara3.   

Abstract

Patients who suffer from lymphedema have impaired immunity and, as a result, are at an increased risk for infections. Furthermore, previous studies have shown that lymphadenectomy impairs acquisition of adaptive immune responses and antibody production in response to foreign antigens. Although it is clear that antigen presentation in lymph nodes plays a key role in adaptive immunity, the cellular mechanisms that regulate impaired immune responses in patients with lymphedema or following lymphatic injury remain unknown. We have previously found that axillary lymph node dissection, both clinically and in a mouse model, results in a marked increase in the number of regulatory T cells in the ipsilateral limb. In this study, we focus on the role of regulatory T cells in immunosuppression and show that regulatory T-cell proliferation in tissues distal to site of lymphatic injury contributes to impaired innate and adaptive immune responses. More importantly, using Foxp3-DTR transgenic mice, we show that depletion of regulatory T cells in the setting of lymphatic injury restores these critical immune-mediated responses. These findings provide additional evidence that immune responses following lymphatic injury play a key role in mediating the pathology of lymphedema.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28942366      PMCID: PMC5794510          DOI: 10.1016/j.jid.2017.09.011

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  36 in total

1.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

2.  Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.

Authors:  Ira L Savetsky; Jeremy S Torrisi; Daniel A Cuzzone; Swapna Ghanta; Nicholas J Albano; Jason C Gardenier; Walter J Joseph; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-23       Impact factor: 4.733

Review 3.  Is FOXP3 a bona fide marker for human regulatory T cells?

Authors:  Maria-Grazia Roncarolo; Silvia Gregori
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

4.  Erysipelas of the upper extremity following locoregional therapy for breast cancer.

Authors:  Nagi S El Saghir; Zaher K Otrock; Abdul Rahman N Bizri; Marwan M Uwaydah; Gerard O Oghlakian
Journal:  Breast       Date:  2005-06-28       Impact factor: 4.380

5.  Lymphatic dysfunction in the apparently clinically normal contralateral limbs of patients with unilateral lower limb swelling.

Authors:  Katherine M Burnand; Daphne M Glass; Peter S Mortimer; Adrien Michael Peters
Journal:  Clin Nucl Med       Date:  2012-01       Impact factor: 7.794

6.  Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.

Authors:  Na Yin; Nan Zhang; Jiangnan Xu; Qixin Shi; Yaozhong Ding; Jonathan S Bromberg
Journal:  Transplantation       Date:  2011-07-15       Impact factor: 4.939

7.  Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.

Authors:  Maria A Curotto de Lafaille; Nino Kutchukhidze; Shiqian Shen; Yi Ding; Herman Yee; Juan J Lafaille
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

8.  Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.

Authors:  Lee Gravatt Wilke; Linda M McCall; Katherine E Posther; Pat W Whitworth; Douglas S Reintgen; A Marilyn Leitch; Sheryl G A Gabram; Anthony Lucci; Charles E Cox; Kelly K Hunt; James E Herndon; Armando E Giuliano
Journal:  Ann Surg Oncol       Date:  2006-03-02       Impact factor: 5.344

Review 9.  Cellulitis after axillary lymph node dissection for carcinoma of the breast.

Authors:  M S Simon; R L Cody
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

10.  Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics.

Authors:  Linda J Wammes; Firdaus Hamid; Aprilianto E Wiria; Heri Wibowo; Erliyani Sartono; Rick M Maizels; Hermelijn H Smits; Taniawati Supali; Maria Yazdanbakhsh
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29
View more
  15 in total

1.  Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.

Authors:  Xiaolong Alan Zhou; Abner Louissaint; Alexander Wenzel; Jingyi Yang; Maria Estela Martinez-Escala; Andrea P Moy; Elizabeth A Morgan; Christian N Paxton; Bo Hong; Erica F Andersen; Joan Guitart; Amir Behdad; Lorenzo Cerroni; David M Weinstock; Jaehyuk Choi
Journal:  J Invest Dermatol       Date:  2018-05-30       Impact factor: 8.551

2.  T helper 2 differentiation is necessary for development of lymphedema.

Authors:  Catherine L Ly; Gabriela D García Nores; Raghu P Kataru; Babak J Mehrara
Journal:  Transl Res       Date:  2018-12-21       Impact factor: 7.012

3.  Tumor Lymphatic Function Regulates Tumor Inflammatory and Immunosuppressive Microenvironments.

Authors:  Raghu P Kataru; Catherine L Ly; Jinyeon Shin; Hyeung Ju Park; Jung Eun Baik; Sonia Rehal; Sagrario Ortega; David Lyden; Babak J Mehrara
Journal:  Cancer Immunol Res       Date:  2019-06-11       Impact factor: 11.151

4.  Mouse tail models of secondary lymphedema: fibrosis gradually worsens and is irreversible.

Authors:  Chenxiao Zhou; Wanchun Su; Haotian Han; Na Li; Gang Ma; Lei Cui
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

5.  Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.

Authors:  Jane M Armer; Karla V Ballman; Linda McCall; Pamela L Ostby; Eris Zagar; Henry M Kuerer; Kelly K Hunt; Judy C Boughey
Journal:  JAMA Surg       Date:  2019-09-01       Impact factor: 14.766

6.  A Prospective Study on the Safety and Efficacy of Vascularized Lymph Node Transplant.

Authors:  Stav Brown; Babak J Mehrara; Michelle Coriddi; Leslie McGrath; Michele Cavalli; Joseph H Dayan
Journal:  Ann Surg       Date:  2022-07-15       Impact factor: 13.787

Review 7.  Current Understanding of Pathological Mechanisms of Lymphedema.

Authors:  Cynthia Sung; Sarah Wang; Jerry Hsu; Roy Yu; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-11-25       Impact factor: 4.947

8.  Small Numbers of CD4+ T Cells Can Induce Development of Lymphedema.

Authors:  Catherine L Ly; Daniel A Cuzzone; Raghu P Kataru; Babak J Mehrara
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

Review 9.  Regulation of Immune Function by the Lymphatic System in Lymphedema.

Authors:  Raghu P Kataru; Jung Eun Baik; Hyeung Ju Park; Itay Wiser; Sonia Rehal; Jin Yeon Shin; Babak J Mehrara
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

Review 10.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.